Georgeanna Klingensmith, MD
Chief, Pediatric Clinics
Professor of Pediatrics
BioSketch / Statement of Interest
The evaluation of agents that may alter the rate of progression of islet cell destruction in children with newly diagnosed type I diabetes.
Study of the development of islet cell autoimmunity in genetically high-risk young children.
Evaluation of the development of diabetes autoimmunity in very young relatives of patients with diabetes compared to very young children.
Monitoring of the efficacy of measures designed to assist families in assimilating information concerning type I diabetes.
Evaluating the effect of needle phobia on diabetes control in children and adolescents.